Skip navigation

ChemicalChemical: Amino Acids, Sulfur

The following diseases are associated with Amino Acids, Sulfur or at least one of its descendants. Each association is direct (M marker/mechanism and/or T therapeutic) and/or inferred (via a curated gene interaction).

Showing 1–500 of 2,997Page: 1 2 3 4 5 6First First page | Prev Previous page | Next page Next | Last page Last
  Chemical Disease Direct Evidence Inference Network Inference Score References
1. cysteinyl-leukotriene Asthma M   1
2. Methionine Child Development Disorders, Pervasive M   1
3. S-(1,2,2-trichlorovinyl)-L-cysteine Kidney Diseases M   1
4. Homocysteine Glaucoma M   1
5. Homocysteine Exfoliation Syndrome M   1
6. Methionine Autistic Disorder M Via 7 genes: GAD1; IFNG; IGF1; MIF; NOS2; RELN; SHANK3 56.51 11
7. selenomethylselenocysteine Breast Neoplasms M Via 8 genes: BCL2; CCND1; CDKN1B; ESR1; GPX1; GPX4; JUN; MKI67 52.16 11
8. Homocysteine Autistic Disorder M Via 6 genes: BCL2; CAT; COMT; GPX1; MECP2; MTHFR 41.18 8
9. Homocysteine Coronary Artery Disease M Via 4 genes: CCL2; GPX1; NOS3; VEGFA 35.36 5
10. Homocysteine Schizophrenia M Via 4 genes: CCL2; COMT; MTHFR; TP53 30.49 6
11. Homocysteine Hyperhomocysteinemia M Via 2 genes: MTHFR; MTRR 20.33 7
12. S-Adenosylhomocysteine Autistic Disorder M Via 2 genes: COMT; SLC19A1 17.31 1
13. Homocysteine Heart Defects, Congenital M Via 2 genes: EDN1; MTHFR 16.83 3
14. Homocysteine Parkinson Disease M Via 2 genes: GPX1; SOD1 14.45 2
15. S-Adenosylmethionine Autistic Disorder M Via 2 genes: COMT; SLC19A1 14.07 2
16. Cysteine Autistic Disorder M Via 2 genes: GSTM1; GSTP1 12.58 5
17. Homocysteine Meningomyelocele M Via 1 gene: MTHFR 10.49 1
18. Ethionine Blood Coagulation Disorders M Via 1 gene: CFI 8.65 2
19. Homocysteine Myocardial Infarction M Via 1 gene: NOS3 6.98 2
20. alliin Neovascularization, Pathologic T   1
21. Methionine Liver Cirrhosis, Experimental T Via 9 genes: CYGB; IFNG; IGF1; NOS2; PDGFRB; TGFB1; TGFBR2; TIMP1; TNF 70.58 19
22. Cysteine Liver Cirrhosis, Experimental T Via 8 genes: CYGB; GSTA2; GSTM1; HMOX1; PDGFRB; TGFB1; TGFBR2; TIMP1 65.15 16
23. Acetylcysteine Drug-Induced Liver Injury T Via 10 genes: ALB; BAX; CXCL1; GCLC; HMOX1; IL1B; IL6; MAP3K5; MMP2; PTGS2 64.59 10
24. Acetylcysteine Carcinoma, Squamous Cell T Via 9 genes: ALDH2; CDKN1A; HIF1A; IL8; MMP9; NFE2L2; PTGS2; STAT3; VEGFA 59.85 9
25. Acetylcysteine Neoplasm Metastasis T Via 6 genes: DAPK1; EGFR; MMP2; MMP9; PLAU; TP53 43.86 6
26. S-allylcysteine Prostatic Neoplasms T Via 5 genes: BCL2; CDH1; JUP; KLK3; TGFB1 38.91 12
27. Acetylcysteine Stomach Ulcer T Via 3 genes: NOS2; PTGS2; TNF 16.33 4
28. Acetylcysteine Respiratory Distress Syndrome, Adult T Via 2 genes: ALB; PLA2G4A 15.66 3
29. S-Adenosylmethionine Liver Cirrhosis, Experimental T Via 2 genes: AFP; TGFB1 13.55 5
30. glutamyl-Se-methylselenocysteine Breast Neoplasms T Via 2 genes: CXCL2; JUN 13.28 2
31. Acetylcysteine Cystic Fibrosis T Via 2 genes: CFTR; TGFB1 13.27 5
32. Acetylcysteine Cell Transformation, Neoplastic T Via 2 genes: MMP9; NOS2 12.63 2
33. Acetylcysteine Lung Diseases T Via 2 genes: TGFB1; TNF 11.94 2
34. alliin Neoplasms T Via 1 gene: VEGFA 8.50 2
35. S-allylcysteine Pulmonary Fibrosis T Via 1 gene: TGFB1 8.17 5
36. selenomethylselenocysteine Mammary Neoplasms, Experimental T Via 1 gene: SPP1 7.46 1
37. Acetylcysteine Prostatic Neoplasms   Via 40 genes: AKT1; AR; ATM; BAX; BCL2; CASP9; CCND1; CDH13; CDKN1A; CDKN1B; CHEK2; CYP1A1; EGF; EGFR; EI24; FHIT; HERPUD1; HIF1A; ICAM1; IL24; IL6; IL8; INS; MMP9; NBN; NOS3; NQO1; NR3C1; PARP1; PLAU; PTGS2; SOD2; STAT3; TERT; TGFB1; TGFBR2; TNFSF10; TP53; VEGFA; ZFP36L2 267.65 63
38. Acetylcysteine Breast Neoplasms   Via 28 genes: AKT1; ATM; BCL2; CASP8; CCND1; CDKN1B; CHEK2; CXCL2; CYP1A1; EGF; EGFR; FOS; HMOX1; IL1B; IL24; IL6; IL8; JUN; MMP3; NFKBIA; NOS2; NQO1; PTGS2; SNAI1; STAT3; TANK; TNF; TP53 180.37 27
39. Ethionine Liver Cirrhosis, Experimental   Via 19 genes: ABCB1A; ADH4; AFP; AGT; AGTR1A; ALDH1A1; ALDH2; CDO1; CES2; FMO1; GULO; HAO2; IGF1; IGFBP2; INHBE; KRT8; OBP3; PLG; RNASE4 136.16 7
40. Acetylcysteine Lung Neoplasms   Via 20 genes: CASP8; CCND1; CDKN1A; CDKN1B; DAPK1; EGFR; FHIT; FOS; HMOX1; IL24; JUNB; MAPK1; MAPK14; MAPK3; NOS2; TERT; TGFB1; TGFBR2; TNF; TP53 132.38 25
41. Ethionine Prostatic Neoplasms   Via 19 genes: ARL6IP1; BNIP3; CBR1; CLPTM1L; CSRP1; DCXR; DNAJC3; ERP29; GSTT1; IGF1; NR3C1; PDIA3; PGRMC1; PRDX2; RNASE4; RPN2; RPS19; SERINC3; SURF4 128.61 9
42. Acetylcysteine Liver Cirrhosis, Experimental   Via 18 genes: ADIPOQ; AGT; ALDH2; CCL2; EDN1; FGF2; HGF; HMOX1; ID2; IL1B; MMP2; MMP9; NOS2; PTGS2; TGFB1; TGFBR2; TNF; VEGFA 114.39 26
43. Acetylcysteine Stomach Neoplasms   Via 17 genes: CASP8; CDKN1A; CDKN1B; EGFR; FHIT; HBEGF; HMOX1; IL1B; IL8; JUN; MAPK8; NOS3; PLAU; PTGS2; SNAI1; SOD2; TNF 111.12 13
44. Acetylcysteine Pulmonary Fibrosis   Via 12 genes: CCL2; CCL5; CXCL2; EGF; FGF2; HGF; HMOX1; IL1B; IL6; IL8; TGFB1; TNF 89.00 10
45. Acetylcysteine Colorectal Neoplasms   Via 13 genes: AKT1; ALDH2; BCL2; CASP8; CCND1; CHEK2; EGFR; PPARG; PTGS2; TGFBR1; TNFSF10; TP53; TXNRD1 86.64 19
46. Acetylcysteine Carcinoma, Hepatocellular   Via 13 genes: AR; CASP8; CDH13; CYP1A1; EGF; EGFR; FOS; HTATIP2; IL6; PTGS2; TERT; TGFB1; TP53 85.95 12
47. Buthionine Sulfoximine Breast Neoplasms   Via 13 genes: BCL2; CCND1; CDKN1B; CYP1A1; FOS; HMOX1; IL6; JUN; NOS2; NQO1; STAT3; TNF; TP53 85.90 15
48. Buthionine Sulfoximine Prostatic Neoplasms   Via 13 genes: BCL2; CCND1; CDKN1A; CDKN1B; CYP1A1; HIF1A; IL10; IL6; NQO1; SOD2; STAT3; TGFBR2; TP53 84.44 21
49. Acetylcysteine Reperfusion Injury   Via 10 genes: CDKN1A; CXCL1; EFNB2; EGF; FGF2; HGF; KDR; SELE; TERT; TNF 81.43 4
50. selenomethylselenocysteine Prostatic Neoplasms   Via 12 genes: AR; BCL2; CCND1; CDKN1B; CYP3A5; ESR1; FASLG; GADD45A; KLK3; PRKCZ; SEPP1; TNFSF10 81.34 28
51. Buthionine Sulfoximine Lung Neoplasms   Via 11 genes: CCND1; CDKN1A; CDKN1B; FOS; HMOX1; IL10; JUNB; NOS2; TGFBR2; TNF; TP53 79.08 12
52. Acetylcysteine Esophageal Neoplasms   Via 11 genes: ALDH2; BAX; CASP8; CCND1; CDH13; CDKN1A; HIF1A; NOS2; PTGS2; TGFBR2; TP53 77.69 14
53. Acetylcysteine Asthma   Via 11 genes: ALDH2; BCL2; CAT; CCL2; CD14; HMOX1; ICAM1; MMP9; TGFB1; TNF; VEGFA 74.15 16
54. Acetylcysteine Oral Submucous Fibrosis   Via 8 genes: COL1A1; COL1A2; FGF2; MMP2; MMP9; PTGS2; TGFB1; TNF 66.24 1
55. S-(1,1,2,2-tetrafluoroethyl)cysteine Prostatic Neoplasms   Via 10 genes: ATF3; CCND1; CDKN1A; CREG1; EIF2AK2; GADD45A; GDF15; HSPA1A; TOP2A; VEGFA 65.84 13
56. Selenomethionine Prostatic Neoplasms   Via 10 genes: AR; EGFR; GPX3; GSTP1; HPN; IL8; KLK3; PRKCZ; TGFBR2; TP53 63.90 29
57. Acetylcysteine Liver Cirrhosis   Via 8 genes: FGF2; HGF; IL6; IL8; MMP2; PLAU; SPP1; STAT1 61.39 7
58. Selenomethionine Lung Neoplasms   Via 9 genes: EGFR; FOS; GPX1; GPX3; GSTP1; MAPK1; MAPK3; TGFBR2; TP53 60.34 11
59. S-(1,1,2,2-tetrafluoroethyl)cysteine HIV Infections   Via 7 genes: BAG3; BIRC3; CDKN1A; GADD45A; HSP90AA1; HSPB1; MDM2 59.88 2
60. Acetylcysteine Liver Diseases   Via 9 genes: CCL2; CD86; HMOX1; MMP9; NFKB1; NOS2; NQO1; SOD1; TXN 58.02 10
61. Acetylcysteine Coronary Artery Disease   Via 7 genes: CCL2; CD40LG; HMOX1; NOS3; PTGS2; TERT; VEGFA 57.29 7
62. S-Nitroso-N-Acetylpenicillamine Hernia, Diaphragmatic   Via 6 genes: EDN1; ELN; FGF2; NPPA; SFTPB; SFTPC 56.84 8
63. Homocysteine Prostatic Neoplasms   Via 9 genes: BAX; BCL2; COMT; MMP9; MTHFR; NOS3; TP53; VEGFA; VIM 56.56 13
64. Acetylcysteine Hernia, Diaphragmatic   Via 8 genes: AGT; EDN1; FGF2; ICAM1; IL6; NOS3; TGFB1; TNF 55.12 10
65. Acetylcysteine Mesothelioma   Via 7 genes: CDKN1B; DIO2; FGF2; FHIT; SOD2; SPP1; TXNRD1 54.68 9
66. Acetylcysteine Alzheimer Disease   Via 9 genes: BAX; BCL2; CASP3; HMOX1; IL1B; NOS3; PLAU; PPARG; TNF 54.58 7
67. lactacystin Breast Neoplasms   Via 8 genes: CCND1; CDKN1B; COMT; CTNNB1; IL6; IL8; TNF; TP53 54.18 13
68. lactacystin Prostatic Neoplasms   Via 8 genes: CCND1; CDKN1B; COMT; CTNNB1; HIF1A; IL6; IL8; TP53 52.32 11
69. S-Nitroso-N-Acetylpenicillamine Liver Cirrhosis, Experimental   Via 7 genes: EDN1; FGF2; GOT1; GSTA2; HMOX1; IFNG; MME 52.12 10
70. S-Adenosylmethionine Prostatic Neoplasms   Via 7 genes: ATF3; COMT; CYP2E1; GNMT; KLF6; RNASEL; TGFB1 51.40 9
71. S-Nitroso-N-Acetylpenicillamine Lung Neoplasms   Via 7 genes: GPX1; HMOX1; MAPK1; MAPK3; NPPA; SFTPB; TP53 50.19 10
72. Acetylcysteine Carcinoma, Non-Small-Cell Lung   Via 7 genes: DAPK1; FHIT; GCLC; IL8; NQO1; TP53; VEGFA 49.51 6
73. Acetylcysteine Autistic Disorder   Via 9 genes: AR; BCL2; CAT; EGF; EGR2; IL6; NOS2; PLA2G4A; PTGS2 49.18 9
74. Buthionine Sulfoximine Liver Cirrhosis, Experimental   Via 7 genes: GPT; HMOX1; IGFBP1; IL10; NOS2; TGFBR2; TNF 48.23 16
75. Acetylcysteine Skin Neoplasms   Via 7 genes: CASP8; FLT1; HIF1A; MMP9; NFE2L2; PTGS2; TGFB1 48.19 6
76. Acetylcysteine Liver Neoplasms   Via 7 genes: CDKN1B; FHIT; HMOX1; MAPK14; STAT3; TNFSF10; TP53 47.76 8
77. Acetylcysteine Colonic Neoplasms   Via 8 genes: BCL2; CCND1; ICAM1; IL1B; MMP9; TNFSF10; TP53; VEGFA 47.70 9
78. Acetylcysteine Cardiomegaly   Via 6 genes: AGT; ATP2A2; FGF2; NOS3; PLD1; PLD2 47.68 6
79. Methionine Oral Submucous Fibrosis   Via 5 genes: COL1A1; IFNG; TGFB1; TIMP1; TNF 47.64 1
80. Homocysteine Breast Neoplasms   Via 7 genes: BCL2; COMT; GPX1; MTHFR; MTR; NFKBIA; TP53 47.18 14
81. Acetylcysteine Pancreatic Neoplasms   Via 7 genes: CYP2B1; HIF1A; IL24; PLAU; PTGS2; TNF; TP53 47.16 10
82. Cysteine Prostatic Neoplasms   Via 7 genes: AKT1; CCND1; CDKN1B; GSTM1; GSTP1; TGFB1; TGFBR2 47.07 10
83. S-Nitroso-N-Acetylpenicillamine Prostatic Neoplasms   Via 7 genes: BCL2; CALCA; HSD3B1; MME; NPPA; SOD2; TP53 46.62 10
84. Buthionine Sulfoximine Esophageal Neoplasms   Via 6 genes: CCND1; CDKN1A; HIF1A; NOS2; TGFBR2; TP53 46.08 6
85. S-nitro-N-acetylpenicillamine Breast Neoplasms   Via 6 genes: BIRC5; CYP19A1; IL6; JUN; PTGS2; STAT3 45.89 8
86. Ethionine Stomach Neoplasms   Via 7 genes: BNIP3; CA2; DPYD; ENO1; KRT8; PGAM1; SERPINA1 45.65 5
87. Cysteine Lung Neoplasms   Via 6 genes: CCND1; CDKN1B; GSTP1; HMOX1; TGFB1; TGFBR2 45.07 10
88. S-nitro-N-acetylpenicillamine Prostatic Neoplasms   Via 6 genes: BNIP3; CALCA; CYP19A1; IL6; PTGS2; STAT3 44.94 11
89. selenomethylselenocysteine Leukemia, Myelogenous, Chronic, BCR-ABL Positive   Via 4 genes: ARNTL; CRY2; PER2; PER3 44.74 1
90. Acetylcysteine Sepsis   Via 6 genes: CASP3; MAPK1; MAPK3; MMP9; TGFB1; TNF 44.28 2
91. Homocysteine Cardiovascular Diseases   Via 5 genes: CCL2; EDN1; GH1; MTHFR; VCAM1 44.02 3
92. Acetylcysteine Carcinoma, Transitional Cell   Via 5 genes: APAF1; CDKN1A; DAPK1; PLAU; PTGS2 43.88 6
93. Acetylcysteine Diabetes Mellitus, Type 2   Via 7 genes: CAT; EDN1; HMOX1; IL6; NFKB1; PPARG; VEGFA 43.65 5
94. Buthionine Sulfoximine Colorectal Neoplasms   Via 6 genes: BCL2; CCND1; PPARG; TGFBR1; TP53; TXNRD1 43.50 11
95. lactacystin Lung Neoplasms   Via 6 genes: BCL2L1; CCND1; CDKN1B; CTNNB1; TNF; TP53 42.36 10
96. Ethionine Carcinoma, Hepatocellular   Via 6 genes: ADD1; AFP; APCS; DPYD; GJB1; PYGL 42.25 6
97. Acetylcysteine Glioma   Via 6 genes: MGMT; PPARG; PTGS2; SPP1; TERT; TP53 42.16 7
98. Acetylcysteine Glioblastoma   Via 6 genes: EGF; IL1B; IL8; MMP2; MMP9; VEGFA 41.19 2
99. Homocysteine Liver Cirrhosis, Experimental   Via 6 genes: ACHE; CCL2; EDN1; GH1; MMP9; VEGFA 40.93 7
100. Acetylcysteine Arsenic Poisoning   Via 6 genes: CXCL2; ID2; IL1B; SOD2; TNF; TP53 39.29 3
101. Buthionine Sulfoximine Stomach Neoplasms   Via 6 genes: CDKN1A; CDKN1B; HMOX1; JUN; SOD2; TNF 39.24 5
102. Methionine Breast Neoplasms   Via 6 genes: ABCG2; AKT1; IFNG; IGF1; NOS2; TNF 39.07 6
103. selenomethylselenocysteine Leukemia   Via 5 genes: AR; BCL2; CCND1; ESR1; PRKCZ 38.89 5
104. S-(1,1,2,2-tetrafluoroethyl)cysteine Breast Neoplasms   Via 6 genes: BIRC5; CCND1; FHL2; HMOX1; HSPA1B; TOP2A 38.70 8
105. Acetylcysteine Skin Diseases   Via 6 genes: CXCL2; ID2; IL1B; PTGS2; SOD2; TNF 38.63 2
106. Acetylcysteine Amyotrophic Lateral Sclerosis   Via 5 genes: CD40LG; PLA2G4A; PTGS2; SOD1; TP53 37.77 9
107. Buthionine Sulfoximine Diabetes Mellitus, Type 2   Via 5 genes: CAT; HMOX1; IL6; INS1; PPARG 37.57 4
108. Acetylcysteine Carcinoma, Renal Cell   Via 5 genes: APAF1; DAPK1; FLT1; PTGS2; TP53 37.48 4
109. Acetylcysteine Cardiovascular Diseases   Via 5 genes: CCL2; EDN1; ICAM1; PON2; SELE 37.32 2
110. lactacystin Carcinoma, Hepatocellular   Via 5 genes: BCL2L1; COMT; CTNNB1; IL6; TP53 37.09 8
111. N-Formylmethionine Leucyl-Phenylalanine Breast Neoplasms   Via 6 genes: AKT1; IL1B; IL6; IL8; PTGS2; TNF 36.71 6
112. selenomethylselenocysteine Colorectal Neoplasms   Via 5 genes: BCL2; CCND1; GPX4; SEPP1; TNFSF10 36.65 5
113. Homocysteine Alzheimer Disease   Via 5 genes: APP; BAX; BCL2; MTHFR; NOS3 36.51 15
114. Homocysteine Asthma   Via 5 genes: BCL2; CAT; CCL2; MMP9; VEGFA 36.32 7
115. Selenomethionine Neoplasm Recurrence, Local   Via 4 genes: AR; GRK6; KLK3; PARVB 36.20 3
116. Ethionine Adenocarcinoma   Via 5 genes: CA2; ENO1; KRT8; PGAM1; SERPINA1 35.60 1
117. Homocysteine NEURAL TUBE DEFECTS, FOLATE-SENSITIVE   Via 3 genes: MTHFR; MTR; MTRR 35.60 1
118. S-(1,2-dichlorovinyl)cysteine Prostatic Neoplasms   Via 5 genes: BAX; BCL2; CASP9; PARP1; TP53 35.49 6
119. Buthionine Sulfoximine Asthma   Via 5 genes: BCL2; CAT; HMOX1; IL12B; TNF 35.39 6
120. N-Formylmethionine Leucyl-Phenylalanine Fever   Via 4 genes: IL1B; IL6; IL8; TNF 35.21 1
121. Acetylcysteine Obesity   Via 5 genes: ADIPOQ; CPE; ICAM1; NQO1; PPARG 35.16 5
122. Acetylcysteine Myocardial Infarction   Via 5 genes: GCLC; GCLM; NOS2; NOS3; OLR1 35.13 7
123. Homocysteine Colonic Neoplasms   Via 5 genes: BCL2; MMP9; MTHFR; TP53; VEGFA 35.06 7
124. S-Nitroso-N-Acetylpenicillamine Pulmonary Fibrosis   Via 4 genes: CALCA; ELN; FGF2; HMOX1 34.98 4
125. Selenomethionine Autistic Disorder   Via 5 genes: AR; GPX1; GSTP1; LASP1; SEMA5A 34.67 5
126. S-(1,1,2,2-tetrafluoroethyl)cysteine Colorectal Neoplasms   Via 5 genes: BIRC5; CCND1; PPARG; TK1; TXNRD1 34.67 5
127. Buthionine Sulfoximine Mesothelioma   Via 4 genes: CDKN1B; DIO2; SOD2; TXNRD1 34.28 5
128. Ethionine Metabolism, Inborn Errors   Via 4 genes: ACACA; DECR1; MUT; OGDH 34.28 4
129. selenomethylselenocysteine Lung Neoplasms   Via 5 genes: CCND1; CDKN1B; ESR1; GPX1; SEPP1 33.88 8
130. Acetylcysteine Psoriasis   Via 5 genes: IL6; TNF; TNFAIP3; TP53; VEGFA 33.74 4
131. Ethionine Colorectal Neoplasms   Via 5 genes: ALDH2; DPYD; GGH; GPX4; NME2 33.63 7
132. Buthionine Sulfoximine Alzheimer Disease   Via 5 genes: BCL2; CASP3; HMOX1; PPARG; TNF 33.62 4
133. N-Formylmethionine Leucyl-Phenylalanine Lung Neoplasms   Via 5 genes: MAPK1; MAPK14; MAPK3; MPO; TNF 33.59 5
134. Selenomethionine Breast Neoplasms   Via 6 genes: EGFR; FOS; GPX1; IL1B; IL8; TP53 33.59 9
135. Methionine Prostatic Neoplasms   Via 5 genes: AKT1; IGF1; MIF; TGFB1; TGFBR2 33.37 6
136. Acetylcysteine Myocardial Ischemia   Via 4 genes: FGF2; HGF; NOS3; VEGFA 33.24 6
137. S-(1,1,2,2-tetrafluoroethyl)cysteine Liver Cirrhosis, Experimental   Via 5 genes: CYP3A13; GSTA2; HGF; HMOX1; VEGFA 33.24 12
138. Cysteine Breast Neoplasms   Via 5 genes: AKT1; CCND1; CDKN1B; HMOX1; RB1 33.15 5
139. Acetylcysteine Leukemia, Lymphocytic, Chronic, B-Cell   Via 5 genes: ATM; CCND1; IL6; PTGS2; TP53 33.10 5
140. N-Formylmethionine Leucyl-Phenylalanine Stomach Neoplasms   Via 5 genes: IL1B; IL8; MAPK8; PTGS2; TNF 33.07 6
141. Acetylcysteine Hypertension   Via 5 genes: AGT; EDN1; INS; NOS3; PTGS2 32.73 10
142. Buthionine Sulfoximine Colitis, Ulcerative   Via 4 genes: IL10; IL12B; RELA; STAT3 32.56 5
143. S-(1,1,2,2-tetrafluoroethyl)cysteine Stomach Neoplasms   Via 5 genes: BIRC5; CDKN1A; GADD45A; HMOX1; IRF1 32.47 4
144. Homocysteine Lung Neoplasms   Via 5 genes: GPX1; MAPK1; MAPK3; MTHFR; TP53 32.31 7
145. S-Adenosylmethionine Carcinoma, Hepatocellular   Via 4 genes: AFP; COMT; TGFB1; UBD 32.28 4
146. S-nitro-N-acetylpenicillamine Stomach Neoplasms   Via 4 genes: BIRC5; BNIP3; JUN; PTGS2 32.14 4
147. Ethionine Lung Neoplasms   Via 5 genes: CLPTM1L; DPYD; GJB1; GPX1; SERPINA1 32.06 6
148. Acetylcysteine Adenocarcinoma   Via 5 genes: DAPK1; PLAU; PTGS2; TGFB1; TP53 31.90 8
149. selenomethylselenocysteine Mesothelioma   Via 4 genes: CDKN1B; ESR1; PGR; SPP1 31.85 4
150. S-(1,1,2,2-tetrafluoroethyl)cysteine Lung Neoplasms   Via 5 genes: BIRC5; CCND1; CDKN1A; HMOX1; IRF1 31.69 8
151. S-Adenosylmethionine Down Syndrome   Via 3 genes: GSTM2; MTR; SLC19A1 31.45 4
152. N-Formylmethionine Leucyl-Phenylalanine Skin Diseases   Via 4 genes: IL1B; PTGS2; TNF; TNFAIP6 31.40 2
153. Selenomethionine Carcinoma, Hepatocellular   Via 5 genes: AR; EGFR; FOS; GSTP1; TP53 31.39 5
154. Cysteine Asthma   Via 4 genes: GSTM1; GSTP1; HMOX1; TGFB1 31.24 5
155. Acetylcysteine Schizophrenia   Via 5 genes: AKT1; BTG1; CCL2; IL1B; TP53 31.11 5
156. Acetylcysteine Urinary Bladder Neoplasms   Via 5 genes: CDKN1A; EGFR; PTGS2; TERT; TP53 31.03 8
157. Homocysteine Lymphoma, Follicular   Via 3 genes: BCL2; MTHFR; MTR 30.93 3
158. Acetylcysteine Arthritis, Rheumatoid   Via 5 genes: MMP2; PTGS2; TNF; TNFAIP3; VEGFA 30.91 7
159. Acetylcysteine HYPERTENSION, ESSENTIAL   Via 4 genes: AGT; NOS2; NOS3; SELE 30.89 1
160. Selenomethionine Head and Neck Neoplasms   Via 4 genes: EGFR; GPX1; MAPK1; MAPK3 30.84 2
161. Acetylcysteine Cholangiocarcinoma   Via 4 genes: EGFR; IL6; NOS2; PTGS2 30.79 3
162. Acetylcysteine Craniofacial Abnormalities   Via 5 genes: APAF1; EDN1; EGFR; MMP2; TGFBR2 30.69 10
163. Selenomethionine Colonic Neoplasms   Via 4 genes: GRK6; IL1B; PARVB; TP53 30.68 4
164. N-Formylmethionine Leucyl-Phenylalanine Pulmonary Fibrosis   Via 4 genes: IL1B; IL6; IL8; TNF 30.56 4
165. Acetylcysteine Carcinoma   Via 4 genes: BCL2; EGFR; FHIT; PTGS2 30.55 4
166. S-Nitroso-N-Acetylpenicillamine Breast Neoplasms   Via 5 genes: BCL2; GPX1; HMOX1; IFNG; TP53 30.35 10
167. N,N-diacetylcystine Arthritis, Rheumatoid   Via 3 genes: IL2RA; PTPRC; TNF 30.27 3
168. Buthionine Sulfoximine Psoriasis   Via 4 genes: IL12B; IL6; TNF; TP53 30.22 5
169. Acetylcysteine Berylliosis   Via 4 genes: GCLM; IL6; TGFB1; TNF 30.14 7
170. S-(1,1,2,2-tetrafluoroethyl)cysteine Carcinoma, Non-Small-Cell Lung   Via 4 genes: ATF3; BIRC5; GCLC; VEGFA 30.11 4
171. Buthionine Sulfoximine Carcinoma, Squamous Cell   Via 4 genes: CDKN1A; HIF1A; NFE2L2; STAT3 30.07 4
172. Acetylcysteine Ovarian Neoplasms   Via 5 genes: AKT1; CDKN1B; EGFR; MAPK1; MAPK3 29.93 2
173. Selenomethionine Craniofacial Abnormalities   Via 4 genes: COL2A1; EGFR; TBX1; TGFBR2 29.82 7
174. S-allylcysteine Breast Neoplasms   Via 4 genes: BCL2; CASP8; CDH1; NOS2 29.69 8
175. Buthionine Sulfoximine Liver Neoplasms   Via 4 genes: CDKN1B; HMOX1; STAT3; TP53 29.39 5
176. Buthionine Sulfoximine Autistic Disorder   Via 5 genes: BCL2; CAT; IL10; IL6; NOS2 29.26 5
177. Homocysteine Colorectal Neoplasms   Via 4 genes: BCL2; MTHFR; MTRR; TP53 29.20 16
178. Acetylcysteine Osteoporosis, Postmenopausal   Via 4 genes: CAT; IL1B; IL6; TNF 29.04 2
179. Homocysteine Liver Diseases   Via 4 genes: CCL2; MMP9; MTHFR; SOD1 28.95 4
180. N-Formylmethionine Leucyl-Phenylalanine Prostatic Neoplasms   Via 5 genes: AKT1; IL6; IL8; PTGS2; VEGFA 28.90 11
181. S-(1,1,2,2-tetrafluoroethyl)cysteine Colonic Neoplasms   Via 4 genes: BIRC5; CCND1; KLF13; VEGFA 28.78 4
182. Cysteine Oral Submucous Fibrosis   Via 3 genes: COL1A1; TGFB1; TIMP1 28.67 1
183. Homocysteine Infertility, Male   Via 3 genes: MTHFR; MTR; MTRR 28.54 1
184. Ethionine Breast Neoplasms   Via 5 genes: AFP; DPYD; GPX1; GPX4; IGF1 28.41 5
185. N-Formylmethionine Leucyl-Phenylalanine Leukemia, Promyelocytic, Acute   Via 3 genes: AKT1; ITGAM; ITGB2 28.19 2
186. Acetylcysteine Melanoma   Via 5 genes: CASP8; FLT1; PTGS2; TNF; TP53 28.06 6
187. Ethionine Drug-Induced Liver Injury   Via 4 genes: APOH; ENO1; GSTT1; PZP 27.98 2
188. S-Adenosylmethionine Oral Submucous Fibrosis   Via 3 genes: COL1A1; COL1A2; TGFB1 27.92 1
189. Methionine Sepsis   Via 3 genes: MIF; TGFB1; TNF 27.89 3
190. Acetylcysteine Fever   Via 4 genes: IL1B; IL6; IL8; TNF 27.66 1
191. Acetylcysteine Multiple Myeloma   Via 4 genes: BTG1; CCL2; CCND1; NQO1 27.50 3
192. Buthionine Sulfoximine Liver Diseases   Via 4 genes: HMOX1; NOS2; NQO1; SOD1 27.15 7
193. Methionine Lung Neoplasms   Via 4 genes: NOS2; TGFB1; TGFBR2; TNF 27.05 5
194. Acetylcysteine Osteoporosis   Via 4 genes: COL1A1; COL1A2; IL6; TGFB1 27.01 3
195. Selenomethionine Liver Cirrhosis, Experimental   Via 4 genes: IL1B; MMP1; PLG; TGFBR2 26.85 5
196. S-Adenosylhomocysteine OSTEOGENESIS IMPERFECTA, TYPE IV   Via 2 genes: COL1A1; COL1A2 26.82 1
197. S-Adenosylhomocysteine EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT   Via 2 genes: COL1A1; COL1A2 26.82 1
198. lactacystin Stomach Neoplasms   Via 4 genes: CDKN1B; IL8; MAPK8; TNF 26.73 4
199. Acetylcysteine Myocardial Stunning   Via 3 genes: ATP2A2; NOS2; TNF 26.59 2
200. Ethionine Carcinoma, Squamous Cell   Via 4 genes: ALDH2; CSNK2B; GPX1; GSTT1 26.35 4
201. N-Formylmethionine Leucyl-Phenylalanine Osteoporosis, Postmenopausal   Via 3 genes: IL1B; IL6; TNF 26.26 1
202. lactacystin Diabetes Mellitus, Type 2   Via 3 genes: IL6; INS1; MAPK8IP1 26.11 2
203. 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine Entamoebiasis   Via 2 genes: IL10; IL2 26.09 1
204. Acetylcysteine Colitis, Ulcerative   Via 4 genes: IL1B; IL8; RELA; STAT3 25.98 3
205. Buthionine Sulfoximine Berylliosis   Via 3 genes: GCLM; IL6; TNF 25.98 5
206. lactacystin Parkinson Disease   Via 3 genes: PARK7; SNCA; SOD1 25.92 13
207. Ethionine Hyperlipoproteinemia Type II   Via 3 genes: APOA4; LIPC; PON2 25.70 1
208. lactacystin Fever   Via 3 genes: IL6; IL8; TNF 25.52 1
209. S-Nitroso-N-Acetylpenicillamine Autistic Disorder   Via 4 genes: BCL2; CALCA; GPX1; IFNG 25.51 4
210. S-Adenosylmethionine Sepsis   Via 3 genes: MAPK1; MAPK3; TGFB1 25.38 2
211. Thiopronine Myocardial Stunning   Via 2 genes: NOS2; TNF 25.34 1
212. S-nitro-N-acetylpenicillamine Colorectal Neoplasms   Via 3 genes: BIRC5; PTGS2; SMAD4 25.24 5
213. S-Adenosylmethionine Osteoporosis   Via 3 genes: COL1A1; COL1A2; TGFB1 25.23 2
214. selenomethylselenocysteine Infertility, Male   Via 3 genes: AR; GPX4; SEPP1 25.23 4
215. Acetylcysteine Leukemia   Via 4 genes: AR; BCL2; CCND1; MGMT 25.18 4
216. Buthionine Sulfoximine Osteoporosis, Postmenopausal   Via 3 genes: CAT; IL6; TNF 25.18 2
217. N-Formylmethionine Leucyl-Phenylalanine Sepsis   Via 3 genes: MAPK1; MAPK3; TNF 25.15 1
218. S-Nitroso-N-Acetylpenicillamine Hypertension   Via 3 genes: EDN1; ELN; NPPA 25.14 6
219. Acetylcysteine Bone Neoplasms   Via 3 genes: MMP2; MMP9; PLAU 25.09 1
220. Buthionine Sulfoximine Carcinoma, Hepatocellular   Via 4 genes: CYP1A1; FOS; IL6; TP53 25.01 6
221. Acetylcysteine Osteochondrodysplasias   Via 3 genes: BCL2; FLT1; KDR 24.97 1
222. S-Adenosylmethionine Lung Neoplasms   Via 4 genes: CYP2E1; MAPK1; MAPK3; TGFB1 24.94 7
223. Thiopronine PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL   Via 2 genes: NOS2; TNF 24.83 1
224. Ethionine Autistic Disorder   Via 4 genes: CADPS2; GPX1; IGF1; MYO1D 24.70 4
225. Homocysteine Sepsis   Via 3 genes: MAPK1; MAPK3; MMP9 24.66 2
226. N-Formylmethionine Leucyl-Phenylalanine Liver Cirrhosis, Experimental   Via 4 genes: IL1B; PTGS2; TNF; VEGFA 24.65 4
227. S-allylcysteine Colorectal Neoplasms   Via 3 genes: BCL2; CASP8; CDH1 24.64 3
228. Acetylcysteine PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL   Via 3 genes: ICAM1; NOS2; TNF 24.57 1
229. S-Nitroso-N-Acetylpenicillamine SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1   Via 2 genes: SFTPB; SFTPC 24.53 1
230. Cysteine Craniofacial Abnormalities   Via 3 genes: COL2A1; TGFB2; TGFBR2 24.50 5
231. FTI 277 Breast Neoplasms   Via 3 genes: CDKN1B; FGF10; RB1 24.48 3
232. 5-S-glutathionyl-alpha-methyldopa Prostatic Neoplasms   Via 3 genes: GSTA1; GSTM1; GSTP1 24.45 5
233. 5-S-glutathionyldopamine Prostatic Neoplasms   Via 3 genes: GSTA1; GSTM1; GSTP1 24.45 5
234. S-Nitroso-N-Acetylpenicillamine Mesothelioma   Via 3 genes: FGF2; IFNG; SOD2 24.37 4
235. Buthionine Sulfoximine Sepsis   Via 3 genes: CASP3; IL10; TNF 24.36 3
236. Acetylcysteine Osteosarcoma   Via 3 genes: CHEK2; JUN; TP53 24.35 5
237. S-Adenosylmethionine NEURAL TUBE DEFECTS, FOLATE-SENSITIVE   Via 2 genes: MTHFD1; MTR 24.26 1
238. Homocysteine Glioblastoma   Via 3 genes: BCHE; MMP9; VEGFA 24.21 3
239. S-Nitroso-N-Acetylpenicillamine Head and Neck Neoplasms   Via 3 genes: GPX1; MAPK1; MAPK3 24.18 2
240. Buthionine Sulfoximine Crohn Disease   Via 3 genes: IL12B; IL6; TNF 24.12 2
241. S-Nitroso-N-Acetylpenicillamine LIPOID CONGENITAL ADRENAL HYPERPLASIA   Via 2 genes: CYP11A1; STAR 24.12 1
242. Methionine Craniofacial Abnormalities   Via 3 genes: COL2A1; TGFB2; TGFBR2 24.09 5
243. Cysteine Urinary Bladder Neoplasms   Via 3 genes: GSTM1; GSTP1; RB1 23.81 3
244. Acetylcysteine Intestinal Polyps   Via 3 genes: CCND1; JUN; PTGS2 23.78 4
245. Homocysteine Neoplasm Metastasis   Via 3 genes: MMP9; MTHFR; TP53 23.71 3
246. N-Formylmethionine Leucyl-Phenylalanine Arsenic Poisoning   Via 3 genes: IL1B; TNF; TNFAIP6 23.66 1
247. N-Formylmethionine Leucyl-Phenylalanine Glioblastoma   Via 3 genes: IL1B; IL8; VEGFA 23.65 1
248. S-(1,1,2,2-tetrafluoroethyl)cysteine Leukemia, Myeloid, Acute   Via 3 genes: CEBPA; FHL2; HSPB1 23.62 2
249. Homocysteine OROFACIAL CLEFT 1   Via 2 genes: MTHFR; MTR 23.56 1
250. Homocysteine Malnutrition   Via 2 genes: MTHFR; MTR 23.56 1
251. Homocysteine Hypertension   Via 3 genes: EDN1; NOS3; SOD3 23.53 7
252. Homocysteine Hernia, Diaphragmatic   Via 3 genes: EDN1; NOS3; VCAM1 23.46 5
253. N,N-diacetylcystine Multiple Sclerosis   Via 2 genes: IL2RA; PTPRC 23.38 4
254. S-Adenosylmethionine OSTEOGENESIS IMPERFECTA, TYPE IV   Via 2 genes: COL1A1; COL1A2 23.31 1
255. S-Adenosylmethionine EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT   Via 2 genes: COL1A1; COL1A2 23.31 1
256. Homocysteine Head and Neck Neoplasms   Via 3 genes: GPX1; MAPK1; MAPK3 23.31 2
257. N-Formylmethionine Leucyl-Phenylalanine Psoriasis   Via 3 genes: IL6; TNF; VEGFA 23.27 2
258. S-Nitroso-N-Acetylpenicillamine Idiopathic Pulmonary Fibrosis   Via 2 genes: SFTPA1; SFTPC 23.25 1
259. Acetylcysteine Diabetic Nephropathies   Via 3 genes: KDR; TGFB1; VEGFA 23.20 2
260. Buthionine Sulfoximine Glioma   Via 3 genes: MGMT; PPARG; TP53 23.15 3
261. Buthionine Sulfoximine Myocardial Infarction   Via 3 genes: GCLC; GCLM; NOS2 23.11 5
262. Methionine Hernia, Diaphragmatic   Via 3 genes: IGF1; TGFB1; TNF 23.01 3
263. lactacystin Leukemia, Lymphocytic, Chronic, B-Cell   Via 3 genes: CCND1; IL6; TP53 23.00 3
264. lactacystin Carcinoma, Squamous Cell   Via 3 genes: HIF1A; IL8; NFE2L2 22.94 3
265. Acetylcysteine Carotid Artery Diseases   Via 3 genes: CCL2; HMOX1; TP53 22.92 3
266. S-nitro-N-acetylpenicillamine Carcinoma, Hepatocellular   Via 3 genes: BIRC5; IL6; PTGS2 22.87 3
267. Acetylcysteine Myocardial Reperfusion Injury   Via 3 genes: ATP2A2; EDN1; NOS2 22.86 3
268. alliin Myocardial Ischemia   Via 2 genes: FGF2; VEGFA 22.83 4
269. Acetylcysteine Inflammation   Via 4 genes: HMOX1; NGF; NOS2; TNF 22.74 4
270. Acetylcysteine Cardiomyopathies   Via 3 genes: HGF; OLR1; PTGS2 22.74 4
271. lactacystin Psoriasis   Via 3 genes: IL6; TNF; TP53 22.66 2
272. S-Nitroso-N-Acetylpenicillamine Ovarian Neoplasms   Via 3 genes: AQP3; MAPK1; MAPK3 22.65 2
273. lactacystin Hernia, Diaphragmatic   Via 3 genes: AGT; IL6; TNF 22.58 3
274. Buthionine Sulfoximine Leukemia   Via 3 genes: BCL2; CCND1; MGMT 22.55 3
275. Selenomethionine Carcinoma, Non-Small-Cell Lung   Via 3 genes: DUSP3; IL8; TP53 22.53 3
276. S-(1,1,2,2-tetrafluoroethyl)cysteine Leukemia   Via 3 genes: BIRC3; CCND1; TOP2A 22.52 3
277. N-(3-nitratopivaloyl)cysteine ethyl ester Cardiovascular Diseases   Via 2 genes: ICAM1; SELE 22.50 1
278. S-allylcysteine Lung Neoplasms   Via 3 genes: CASP8; NOS2; TGFB1 22.45 6
279. selenomethylselenocysteine OSTEOGENESIS IMPERFECTA, TYPE IV   Via 2 genes: COL1A1; COL1A2 22.42 1
280. selenomethylselenocysteine EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT   Via 2 genes: COL1A1; COL1A2 22.42 1
281. lactacystin Esophageal Neoplasms   Via 3 genes: CCND1; HIF1A; TP53 22.42 3
282. Selenomethionine Arsenic Poisoning   Via 3 genes: IL1B; SSBP1; TP53 22.37 3
283. Acetylcysteine Carcinoma, Adenoid Cystic   Via 3 genes: CCND1; DAPK1; JAG1 22.32 1
284. Selenomethionine Melanoma   Via 3 genes: COL2A1; STX17; TP53 22.27 3
285. Acetylcysteine Salivary Gland Neoplasms   Via 3 genes: CCND1; DAPK1; JAG1 22.26 1
286. Thiopronine Malaria   Via 2 genes: NOS2; TNF 22.22 1
287. N-Formylmethionine Leucyl-Phenylalanine Asthma   Via 3 genes: ALOX5; TNF; VEGFA 22.16 6
288. S-Adenosylmethionine Breast Neoplasms   Via 3 genes: AFP; COMT; MTR 22.15 5
289. lactacystin Pulmonary Fibrosis   Via 3 genes: IL6; IL8; TNF 22.12 4
290. 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine HIV Infections   Via 2 genes: IL10; IL2 22.07 2
291. Acetylcysteine Diabetes Mellitus   Via 3 genes: ADIPOQ; CAT; PTGS2 22.06 3
292. Buthionine Sulfoximine Reperfusion Injury   Via 3 genes: CDKN1A; IL10; TNF 22.05 3
293. S-Adenosylhomocysteine Oral Submucous Fibrosis   Via 2 genes: COL1A1; COL1A2 22.04 1
294. N,N-diacetylcystine Berylliosis   Via 2 genes: IL2RA; TNF 22.00 5
295. Buthionine Sulfoximine Carcinoma, Non-Small-Cell Lung   Via 3 genes: GCLC; NQO1; TP53 21.99 3
296. Acetylcysteine Bronchial Hyperreactivity   Via 3 genes: CCL2; CXCL1; ICAM1 21.97 2
297. lactacystin Pancreatic Neoplasms   Via 3 genes: HIF1A; TNF; TP53 21.93 4
298. Acetylcysteine Pulmonary Disease, Chronic Obstructive   Via 3 genes: HMOX1; TGFB1; TP53 21.83 4
299. S-Nitroso-N-Acetylpenicillamine Diabetes Mellitus, Type 2   Via 3 genes: EDN1; HMOX1; NFKB1 21.82 3
300. S-(1,1,2,2-tetrafluoroethyl)cysteine Ovarian Neoplasms   Via 3 genes: ATF3; BIRC5; GADD45A 21.79 6
301. Acetylcysteine Respiratory Hypersensitivity   Via 3 genes: IL6; SLC39A14; TNF 21.77 2
302. Ethionine Craniofacial Abnormalities   Via 3 genes: ATP6AP2; TMCO1; UFD1L 21.76 3
303. S-Adenosylmethionine Ovarian Neoplasms   Via 3 genes: ATF3; MAPK1; MAPK3 21.70 2
304. Acetylcysteine Intestinal Neoplasms   Via 3 genes: BAX; BCL2; CDKN1A 21.65 4
305. Buthionine Sulfoximine Leukemia, Lymphocytic, Chronic, B-Cell   Via 3 genes: CCND1; IL6; TP53 21.65 3
306. N-Formylmethionine Leucyl-Phenylalanine Melanoma   Via 3 genes: PTGS2; RAC2; TNF 21.65 3
307. selenomethylselenocysteine Liver Neoplasms   Via 3 genes: CDKN1B; ESR1; TNFSF10 21.57 3
308. N-Formylmethionine Leucyl-Phenylalanine Carcinoma, Squamous Cell   Via 3 genes: IL8; PTGS2; VEGFA 21.51 3
309. Cysteine Carcinoma, Hepatocellular   Via 3 genes: GSTP1; RB1; TGFB1 21.40 2
310. Homocysteine Carcinoma, Squamous Cell   Via 3 genes: GPX1; MMP9; VEGFA 21.39 3
311. Ethionine PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA   Via 2 genes: SDHC; SDHD 21.38 1
312. N-Formylmethionine Leucyl-Phenylalanine Colonic Neoplasms   Via 3 genes: ALOX5; IL1B; VEGFA 21.37 2
313. N-Formylmethionine Leucyl-Phenylalanine Ovarian Neoplasms   Via 3 genes: AKT1; MAPK1; MAPK3 21.32 1
314. Homocysteine Stomach Neoplasms   Via 3 genes: DNMT1; MTHFR; NOS3 21.12 3
315. Homocysteine Diabetes Mellitus, Type 2   Via 3 genes: CAT; EDN1; VEGFA 21.11 3
316. N-Formylmethionine Leucyl-Phenylalanine Arthritis, Rheumatoid   Via 3 genes: PTGS2; TNF; VEGFA 21.02 4
317. S-nitro-N-acetylpenicillamine Autistic Disorder   Via 3 genes: CALCA; IL6; PTGS2 20.98 3
318. Cysteine Eye Abnormalities   Via 2 genes: TGFB2; TGFBR2 20.92 2
319. Buthionine Sulfoximine Arsenic Poisoning   Via 3 genes: SOD2; TNF; TP53 20.86 3
320. S-Nitroso-N-Acetylpenicillamine Liver Diseases   Via 3 genes: HMOX1; NFKB1; SOD1 20.82 5
321. S-(1,2-dichlorovinyl)cysteine Breast Neoplasms   Via 3 genes: BCL2; JUN; TP53 20.79 8
322. Selenomethionine Colitis, Ulcerative   Via 3 genes: IL1B; IL8; RELA 20.78 1
323. Buthionine Sulfoximine Pulmonary Fibrosis   Via 3 genes: HMOX1; IL6; TNF 20.75 4
324. S-(1,1,2,2-tetrafluoroethyl)cysteine Carcinoma, Squamous Cell   Via 3 genes: CDKN1A; CEBPA; VEGFA 20.74 3
325. Acetylcysteine Parkinson Disease   Via 3 genes: PARK7; SNCA; SOD1 20.73 13
326. N-Formylmethionine Leucyl-Phenylalanine Alzheimer Disease   Via 3 genes: IL1B; MPO; TNF 20.71 3
327. S-(1,1,2,2-tetrafluoroethyl)cysteine Asthma   Via 3 genes: CD14; HMOX1; VEGFA 20.67 4
328. Methionine Eye Abnormalities   Via 2 genes: TGFB2; TGFBR2 20.64 2
329. Buthionine Sulfoximine Pancreatic Neoplasms   Via 3 genes: HIF1A; TNF; TP53 20.59 4
330. S-nitro-N-acetylpenicillamine Intestinal Polyps   Via 2 genes: JUN; PTGS2 20.57 4
331. Homocysteine Diabetic Angiopathies   Via 2 genes: MTHFR; NOS3 20.46 2
332. Ethionine Liver Diseases   Via 3 genes: AFP; OBP3; SERPINA1 20.43 4
333. Acetylcysteine Malaria   Via 3 genes: ICAM1; NOS2; TNF 20.42 1
334. lactacystin Alzheimer Disease   Via 3 genes: APP; CASP3; TNF 20.35 14
335. S-Adenosylhomocysteine Osteoporosis   Via 2 genes: COL1A1; COL1A2 20.27 1
336. glutamyl-Se-methylselenocysteine Pulmonary Fibrosis   Via 2 genes: CMA1; CXCL2 20.24 2
337. lactacystin Cecal Neoplasms   Via 2 genes: CCND1; CTNNB1 20.24 1
338. S-(1,2-dichlorovinyl)cysteine Osteosarcoma   Via 2 genes: JUN; TP53 20.23 4
339. Ethionine Obesity   Via 3 genes: ENPP1; GPX1; ME1 20.19 3
340. Acetylcysteine Duodenal Ulcer   Via 3 genes: NOS2; PTGS2; TGFB1 20.12 3
341. Selenomethionine Urinary Bladder Neoplasms   Via 3 genes: EGFR; GSTP1; TP53 20.03 4
342. Homocysteine Down Syndrome   Via 2 genes: MTHFR; MTR 20.02 5
343. Acetylcysteine Kidney Neoplasms   Via 3 genes: CYP1A1; PTGS2; TNFSF10 20.02 3
344. N-Formylmethionine Leucyl-Phenylalanine Drug-Induced Liver Injury   Via 3 genes: IL1B; IL6; PTGS2 20.02 3
345. Acetylcysteine OSTEOGENESIS IMPERFECTA, TYPE IV   Via 2 genes: COL1A1; COL1A2 19.98 1
346. Acetylcysteine EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT   Via 2 genes: COL1A1; COL1A2 19.98 1
347. Thiopronine Stomach Ulcer   Via 2 genes: NOS2; TNF 19.94 2
348. Buthionine Sulfoximine Drug-Induced Liver Injury   Via 3 genes: GCLC; HMOX1; IL6 19.84 3
349. S-(1,2-dichlorovinyl)cysteine Intestinal Neoplasms   Via 2 genes: BAX; BCL2 19.84 2
350. S-nitro-N-acetylpenicillamine Arthritis, Experimental   Via 2 genes: CALCA; STAT3 19.82 2
351. Homocysteine Hypertension, Portal   Via 2 genes: NOS3; VEGFA 19.81 2
352. S-(1,1,2,2-tetrafluoroethyl)cysteine Diabetes Mellitus, Type 2   Via 3 genes: HMOX1; PPARG; VEGFA 19.75 2
353. selenomethylselenocysteine Colonic Neoplasms   Via 3 genes: BCL2; CCND1; TNFSF10 19.68 3
354. Buthionine Sulfoximine Hypothermia   Via 2 genes: IL12B; TNF 19.66 1
355. Ethionine Hernia, Diaphragmatic   Via 3 genes: AGT; AGTR1A; IGF1 19.63 2
356. selenomethylselenocysteine Carcinoma, Hepatocellular   Via 3 genes: AR; ESR1; IGF1R 19.60 3
357. Buthionine Sulfoximine Schistosomiasis mansoni   Via 2 genes: NOS2; SOD1 19.58 2
358. selenomethylselenocysteine Chondrosarcoma, Mesenchymal   Via 2 genes: BCL2; MKI67 19.57 1
359. Ethionine Paraganglioma   Via 2 genes: SDHC; SDHD 19.48 2
360. Homocysteine Precursor Cell Lymphoblastic Leukemia-Lymphoma   Via 2 genes: MTHFR; MTRR 19.43 2
361. S-Nitroso-N-Acetylpenicillamine Carcinoma, Small Cell   Via 2 genes: NPPA; TP53 19.42 2
362. S-Nitroso-N-Acetylpenicillamine Colonic Neoplasms   Via 3 genes: BCL2; IFNG; TP53 19.41 5
363. N-Formylmethionine Leucyl-Phenylalanine Multiple Organ Failure   Via 2 genes: ALOX5; TNF 19.41 2
364. Ethionine Glucose Intolerance   Via 2 genes: AGTR1A; LIPC 19.37 2
365. alliin Psoriasis   Via 2 genes: TP53; VEGFA 19.32 2
366. 5-S-glutathionyldopamine Urinary Bladder Neoplasms   Via 2 genes: GSTM1; GSTP1 19.32 2
367. 5-S-glutathionyl-alpha-methyldopa Urinary Bladder Neoplasms   Via 2 genes: GSTM1; GSTP1 19.32 2
368. S-nitro-N-acetylpenicillamine Cholangiocarcinoma   Via 2 genes: IL6; PTGS2 19.31 2
369. Cysteine Pulmonary Emphysema   Via 2 genes: HMOX1; TGFB1 19.29 3
370. FTI 277 Ovarian Neoplasms   Via 2 genes: CDKN1B; RBL2 19.24 2
371. Methionine Hyperhomocysteinemia   Via 2 genes: MTRR; TNF 19.20 3
372. Methionine Myocardial Stunning   Via 2 genes: NOS2; TNF 19.20 1
373. Acetylcysteine Kidney Diseases   Via 3 genes: CDKN1A; TERT; TGFB1 19.14 2
374. Acetylcysteine Head and Neck Neoplasms   Via 3 genes: EGFR; MAPK1; MAPK3 19.11 1
375. S-(1,2-dichlorovinyl)cysteine Carcinoma, Renal Cell   Via 2 genes: APAF1; TP53 19.10 2
376. lactacystin Liver Cirrhosis, Experimental   Via 3 genes: AGT; GSTA2; TNF 19.08 3
377. Selenomethionine Ovarian Neoplasms   Via 3 genes: EGFR; MAPK1; MAPK3 19.01 1
378. 5-S-glutathionyl-alpha-methyldopa Asthma   Via 2 genes: GSTM1; GSTP1 18.99 3
379. 5-S-glutathionyldopamine Asthma   Via 2 genes: GSTM1; GSTP1 18.99 3
380. selenomethylselenocysteine Stomach Neoplasms   Via 3 genes: CDKN1B; GADD45A; JUN 18.99 3
381. Cysteine Osteosarcoma   Via 2 genes: GSTP1; RB1 18.95 2
382. Buthionine Sulfoximine Inflammation   Via 3 genes: HMOX1; NOS2; TNF 18.95 3
383. Cysteine Carotid Artery Diseases   Via 2 genes: GSTP1; HMOX1 18.92 2
384. methylmercury cysteine Endometrial Neoplasms   Via 2 genes: BIRC5; SUZ12 18.91 2
385. N-Formylmethionine Leucyl-Phenylalanine Autistic Disorder   Via 3 genes: IL6; PLA2G4A; PTGS2 18.90 3
386. Acetylcysteine Hypertrophy, Left Ventricular   Via 2 genes: CKM; HBEGF 18.87 2
387. Thiopronine Inflammation   Via 2 genes: NOS2; TNF 18.81 2
388. S-allylcysteine Sepsis   Via 2 genes: CASP3; TGFB1 18.81 1
389. Buthionine Sulfoximine Colonic Neoplasms   Via 3 genes: BCL2; CCND1; TP53 18.78 4
390. Methionine PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL   Via 2 genes: NOS2; TNF 18.69 1
391. S-allylcysteine Duodenal Ulcer   Via 2 genes: NOS2; TGFB1 18.66 3
392. Methionine Myocardial Reperfusion Injury   Via 2 genes: CYBB; NOS2 18.60 1
393. 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine Autistic Disorder   Via 2 genes: IL10; IL2 18.52 2
394. alliin Carcinoma, Non-Small-Cell Lung   Via 2 genes: TP53; VEGFA 18.42 2
395. Selenocysteine Colitis, Ulcerative   Via 2 genes: IL8; RELA 18.40 1
396. Acetylcysteine Aortic Aneurysm   Via 2 genes: MMP9; TGFBR2 18.38 2
397. selenomethylselenocysteine Alzheimer Disease   Via 3 genes: BCL2; CASP3; ESR1 18.37 2
398. N-Formylmethionine Leucyl-Phenylalanine Leukemia, Myelogenous, Chronic, BCR-ABL Positive   Via 2 genes: ALOX5; MAPK14 18.36 3
399. Ethionine Anemia, Diamond-Blackfan   Via 2 genes: RPL11; RPS19 18.35 2
400. Acetylcysteine Li-Fraumeni Syndrome   Via 2 genes: CHEK2; TP53 18.33 4
401. N-Formylmethionine Leucyl-Phenylalanine Entamoebiasis   Via 2 genes: IL1B; IL6 18.32 1
402. Homocysteine Lymphoma   Via 2 genes: MTHFR; MTR 18.32 1
403. Thiorphan Prostatic Neoplasms   Via 2 genes: AKT1; MME 18.30 2
404. Homocysteine Hyperinsulinism   Via 2 genes: GPX1; NOS3 18.29 3
405. Buthionine Sulfoximine Intestinal Polyps   Via 2 genes: CCND1; JUN 18.26 1
406. Buthionine Sulfoximine Myocardial Stunning   Via 2 genes: NOS2; TNF 18.23 1
407. Ethionine Asbestosis   Via 2 genes: GSTT1; SERPINA1 18.23 2
408. selenomethylselenocysteine Prostatic Intraepithelial Neoplasia   Via 2 genes: AR; ESR1 18.22 2
409. N-Formylmethionine Leucyl-Phenylalanine Dermatomyositis   Via 2 genes: IL1B; TNF 18.22 1
410. Cysteine Pulmonary Disease, Chronic Obstructive   Via 2 genes: HMOX1; TGFB1 18.15 3
411. Methionine Female Urogenital Diseases   Via 2 genes: IGF1; TIMP1 18.04 1
412. S-(1,1,2,2-tetrafluoroethyl)cysteine Muscular Dystrophy, Facioscapulohumeral   Via 2 genes: CDKN1A; HSPA1B 17.99 1
413. Acetylcysteine Bronchiectasis   Via 2 genes: ICAM1; TNF 17.97 1
414. Buthionine Sulfoximine Entamoebiasis   Via 2 genes: IL10; IL6 17.97 1
415. N,N-diacetylcystine Hernia, Diaphragmatic   Via 2 genes: NOS3; TNF 17.92 3
416. selenomethylselenocysteine Intestinal Polyps   Via 2 genes: CCND1; JUN 17.92 1
417. Acetylcysteine HIV Infections   Via 3 genes: ALB; BAX; CDKN1A 17.92 2
418. N-Formylmethionine Leucyl-Phenylalanine Hypersensitivity   Via 2 genes: SELP; TNF 17.88 2
419. Buthionine Sulfoximine Multiple Organ Failure   Via 2 genes: IL10; TNF 17.87 2
420. Buthionine Sulfoximine Epilepsy   Via 2 genes: SEPW1; TXNRD1 17.86 1
421. Buthionine Sulfoximine PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL   Via 2 genes: NOS2; TNF 17.72 1
422. Acetylcysteine Atrophy   Via 2 genes: MAPK3; STAT3 17.72 1
423. S-Nitroso-N-Acetylpenicillamine Oral Submucous Fibrosis   Via 2 genes: FGF2; IFNG 17.71 1
424. selenomethylselenocysteine Oral Submucous Fibrosis   Via 2 genes: COL1A1; COL1A2 17.66 1
425. S-Nitroso-N-Acetylpenicillamine Carotid Artery Diseases   Via 2 genes: HMOX1; TP53 17.65 2
426. S-Nitroso-N-Acetylpenicillamine Wounds and Injuries   Via 2 genes: CALCA; HMOX1 17.64 2
427. S-Nitroso-N-Acetylpenicillamine Cardiomyopathy, Dilated   Via 2 genes: CSRP3; GPX1 17.63 2
428. lactacystin Mesothelioma   Via 2 genes: CDKN1B; DIO2 17.57 2
429. lactacystin Hemangiosarcoma   Via 2 genes: CTNNB1; TP53 17.56 2
430. N-Formylmethionine Leucyl-Phenylalanine Cholangiocarcinoma   Via 2 genes: IL6; PTGS2 17.53 2
431. S-(1,1,2,2-tetrafluoroethyl)cysteine Myocardial Ischemia   Via 2 genes: HGF; VEGFA 17.53 4
432. Homocysteine Cell Transformation, Neoplastic   Via 2 genes: MMP9; WNT5A 17.52 2
433. Buthionine Sulfoximine Drug Toxicity   Via 2 genes: HMOX1; IGFBP1 17.49 2
434. S-nitro-N-acetylpenicillamine Carcinoma, Renal Cell   Via 2 genes: BIRC5; PTGS2 17.44 2
435. Homocysteine Myocardial Ischemia   Via 2 genes: NOS3; VEGFA 17.42 4
436. S-(1,1,2,2-tetrafluoroethyl)cysteine Endometrial Neoplasms   Via 2 genes: BIRC5; MSH6 17.40 2
437. S-nitro-N-acetylpenicillamine Pulmonary Fibrosis   Via 2 genes: CALCA; IL6 17.36 2
438. 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine Prostatic Neoplasms   Via 2 genes: IL10; IL2 17.35 4
439. Buthionine Sulfoximine Soft Tissue Neoplasms   Via 2 genes: BCL2; TNF 17.35 3
440. Homocysteine Carotid Artery Diseases   Via 2 genes: CCL2; TP53 17.35 2
441. selenomethylselenocysteine Epilepsy   Via 2 genes: GPX1; SEPW1 17.34 1
442. Buthionine Sulfoximine Occupational Diseases   Via 2 genes: CYP1A1; NQO1 17.33 4
443. lactacystin Medulloblastoma   Via 2 genes: CCNE1; CTNNB1 17.33 2
444. Thiopronine Lung Neoplasms   Via 2 genes: NOS2; TNF 17.27 2
445. N-Formylmethionine Leucyl-Phenylalanine Adenomatous Polyposis Coli   Via 2 genes: AKT1; PTGS2 17.23 1
446. Acetylcysteine Eye Abnormalities   Via 2 genes: APAF1; TGFBR2 17.22 2
447. 5-S-glutathionyl-alpha-methyldopa Liver Cirrhosis, Experimental   Via 2 genes: GSTA2; GSTM1 17.19 2
448. 5-S-glutathionyldopamine Liver Cirrhosis, Experimental   Via 2 genes: GSTA2; GSTM1 17.19 2
449. Acetylcysteine Gallbladder Neoplasms   Via 2 genes: BCL2; KEAP1 17.19 2
450. FTI 277 Urinary Bladder Neoplasms   Via 2 genes: CDKN1A; RB1 17.17 2
451. Buthionine Sulfoximine Carotid Artery Diseases   Via 2 genes: HMOX1; TP53 17.15 2
452. Acetylcysteine Hypertension, Portal   Via 2 genes: NOS3; VEGFA 17.12 2
453. N-Formylmethionine Leucyl-Phenylalanine Amyotrophic Lateral Sclerosis   Via 2 genes: PLA2G4A; PTGS2 17.12 1
454. S-Nitroso-N-Acetylpenicillamine Coronary Artery Disease   Via 2 genes: GPX1; HMOX1 17.10 2
455. S-allylcysteine Liver Diseases   Via 2 genes: JUP; NOS2 17.07 1
456. S-Nitroso-N-Acetylpenicillamine Pulmonary Disease, Chronic Obstructive   Via 2 genes: HMOX1; TP53 17.05 3
457. Homocysteine Adenoma   Via 2 genes: BCL2; MTRR 17.03 3
458. Methionine Berylliosis   Via 2 genes: TGFB1; TNF 16.98 6
459. Thiopronine Liver Cirrhosis, Experimental   Via 2 genes: NOS2; TNF 16.97 2
460. Selenomethionine Pulmonary Disease, Chronic Obstructive   Via 2 genes: MMP1; TP53 16.97 2
461. S-allylcysteine Skin Neoplasms   Via 2 genes: CASP8; TGFB1 16.97 2
462. Buthionine Sulfoximine Osteosarcoma   Via 2 genes: JUN; TP53 16.93 4
463. alliin Colonic Neoplasms   Via 2 genes: TP53; VEGFA 16.93 3
464. Cysteine Fibrosis   Via 2 genes: HMOX1; TGFB1 16.90 3
465. S-Nitroso-N-Acetylpenicillamine Retinal Degeneration   Via 2 genes: BCL2; SOD1 16.89 2
466. selenomethylselenocysteine Autistic Disorder   Via 3 genes: AR; BCL2; GPX1 16.89 3
467. Selenomethionine Stomach Neoplasms   Via 3 genes: EGFR; IL1B; IL8 16.89 3
468. S-(1,2-dichlorovinyl)cysteine Liver Neoplasms, Experimental   Via 2 genes: BCL2; TP53 16.88 2
469. alliin Liver Cirrhosis, Experimental   Via 2 genes: FGF2; VEGFA 16.88 3
470. S-Nitroso-N-Acetylpenicillamine Cardiomegaly   Via 2 genes: FGF2; NPPA 16.87 2
471. Acetylcysteine Glomerulonephritis, IGA   Via 2 genes: AGT; SELE 16.86 2
472. Acetylcysteine Schistosomiasis mansoni   Via 2 genes: NOS2; SOD1 16.81 2
473. N-Formylmethionine Leucyl-Phenylalanine Coronary Artery Disease   Via 2 genes: PTGS2; VEGFA 16.78 2
474. lactacystin Adenoma   Via 2 genes: BCL2L1; CTNNB1 16.76 2
475. Acetylcysteine Cerebral Hemorrhage   Via 2 genes: HMOX1; MMP9 16.76 2
476. Methionine Duodenal Ulcer   Via 2 genes: NOS2; TGFB1 16.72 3
477. Selenomethionine Carcinoma, Basal Cell   Via 2 genes: TP53; XPA 16.66 2
478. lactacystin Osteoporosis, Postmenopausal   Via 2 genes: IL6; TNF 16.66 1
479. Buthionine Sulfoximine Cholangiocarcinoma   Via 2 genes: IL6; NOS2 16.66 2
480. Selenomethionine Carotid Artery Diseases   Via 2 genes: GSTP1; TP53 16.56 1
481. Buthionine Sulfoximine Intestinal Neoplasms   Via 2 genes: BCL2; CDKN1A 16.56 3
482. N-Formylmethionine Leucyl-Phenylalanine Berylliosis   Via 2 genes: IL6; TNF 16.56 4
483. Buthionine Sulfoximine Pulmonary Disease, Chronic Obstructive   Via 2 genes: HMOX1; TP53 16.55 3
484. Cysteine Mesothelioma   Via 2 genes: CDKN1B; GSTM1 16.54 2
485. N,N-diacetylcystine Alzheimer Disease   Via 2 genes: NOS3; TNF 16.53 3
486. lactacystin Berylliosis   Via 2 genes: IL6; TNF 16.49 4
487. Acetylcysteine Hyperinsulinism   Via 2 genes: INS; NOS3 16.49 2
488. Methionine Schizophrenia   Via 2 genes: AKT1; RELN 16.48 3
489. Homocysteine Intestinal Neoplasms   Via 2 genes: BAX; BCL2 16.47 2
490. 5-S-glutathionyldopamine Autistic Disorder   Via 2 genes: GSTM1; GSTP1 16.45 2
491. 5-S-glutathionyl-alpha-methyldopa Autistic Disorder   Via 2 genes: GSTM1; GSTP1 16.45 2
492. Cysteine Osteoporosis   Via 2 genes: COL1A1; TGFB1 16.43 2
493. Methionine Migraine Disorders   Via 2 genes: TGFBR2; TNF 16.40 2
494. Buthionine Sulfoximine Retinal Degeneration   Via 2 genes: BCL2; SOD1 16.39 2
495. Homocysteine Retinal Degeneration   Via 2 genes: BCL2; SOD1 16.32 2
496. Acetylcysteine Metabolic Syndrome X   Via 2 genes: ADIPOQ; CCL2 16.32 4
497. S-allylcysteine Esophageal Neoplasms   Via 2 genes: CASP8; NOS2 16.32 2
498. 2-amino-4-methylthio-3-butenoic acid METHIONINE ADENOSYLTRANSFERASE DEFICIENCY   Via 1 gene: MAT1A 16.29 1
499. S-nitro-N-acetylpenicillamine Leukemia, Lymphocytic, Chronic, B-Cell   Via 2 genes: IL6; PTGS2 16.28 2
500. lactacystin Amyotrophic Lateral Sclerosis   Via 2 genes: SOD1; TP53 16.27 8
Showing 1–500 of 2,997Page: 1 2 3 4 5 6First First page | Prev Previous page | Next page Next | Last page Last